Listed

Xilio Therapeutics, Inc.

XLONasdaqCIK 1840233HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$18.7m, Q2 FY2026
Operating income−$3.5m, Q2 FY2026
Net income−$6.4m, Q2 FY2026
Xilio Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reported2.4Revenue, Q2 FY2024, three months to 2024-06-30$2.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure2.3Revenue, Q3 FY2024, three months to 2024-09-30$2.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure1.7Revenue, Q4 FY2024, three months to 2024-12-31$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure2.9Revenue, Q1 FY2025, three months to 2025-03-31$2.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure8.1Revenue, Q2 FY2025, three months to 2025-06-30$8.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure19.1Revenue, Q3 FY2025, three months to 2025-09-30$19.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure13.7Revenue, Q4 FY2025, three months to 2025-12-31$13.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure12.6Revenue, Q1 FY2026, three months to 2026-03-31$12.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure18.7Revenue, Q2 FY2026, three months to 2026-06-30$18.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure
Research and development$m11.1Research and development, Q3 FY2023, three months to 2023-09-30$11.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figure11.7Research and development, Q4 FY2023, three months to 2023-12-31$11.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-11, accession 0001558370-25-002640. Derived: 12-month figure less the 9-month figure.Report this figure10.4Research and development, Q1 FY2024, three months to 2024-03-31$10.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure11.2Research and development, Q2 FY2024, three months to 2024-06-30$11.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure10.8Research and development, Q3 FY2024, three months to 2024-09-30$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure8.8Research and development, Q4 FY2024, three months to 2024-12-31$8.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure8.3Research and development, Q1 FY2025, three months to 2025-03-31$8.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure15.3Research and development, Q2 FY2025, three months to 2025-06-30$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure14.3Research and development, Q3 FY2025, three months to 2025-09-30$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure18.1Research and development, Q4 FY2025, three months to 2025-12-31$18.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure19.8Research and development, Q1 FY2026, three months to 2026-03-31$19.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure14.6Research and development, Q2 FY2026, three months to 2026-06-30$14.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure
Operating income$m(17.4)Operating income, Q3 FY2023, three months to 2023-09-30−$17.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figure(18.1)Operating income, Q4 FY2023, three months to 2023-12-31−$18.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-11, accession 0001558370-25-002640. Derived: 12-month figure less the 9-month figure.Report this figure(17.5)Operating income, Q1 FY2024, three months to 2024-03-31−$17.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure(14.7)Operating income, Q2 FY2024, three months to 2024-06-30−$14.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure(14.8)Operating income, Q3 FY2024, three months to 2024-09-30−$14.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure(13.6)Operating income, Q4 FY2024, three months to 2024-12-31−$13.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure(13.9)Operating income, Q1 FY2025, three months to 2025-03-31−$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure(14.4)Operating income, Q2 FY2025, three months to 2025-06-30−$14.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure(1.9)Operating income, Q3 FY2025, three months to 2025-09-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure(11.8)Operating income, Q4 FY2025, three months to 2025-12-31−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure(14.1)Operating income, Q1 FY2026, three months to 2026-03-31−$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure(3.5)Operating income, Q2 FY2026, three months to 2026-06-30−$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(16.7)Net income, Q3 FY2023, three months to 2023-09-30−$16.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figure(17.7)Net income, Q4 FY2023, three months to 2023-12-31−$17.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-11, accession 0001558370-25-002640. Derived: 12-month figure less the 9-month figure.Report this figure(17.2)Net income, Q1 FY2024, three months to 2024-03-31−$17.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure(13.9)Net income, Q2 FY2024, three months to 2024-06-30−$13.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure(14.0)Net income, Q3 FY2024, three months to 2024-09-30−$14.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure(13.1)Net income, Q4 FY2024, three months to 2024-12-31−$13.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure(13.3)Net income, Q1 FY2025, three months to 2025-03-31−$13.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure(15.8)Net income, Q2 FY2025, three months to 2025-06-30−$15.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure(16.3)Net income, Q3 FY2025, three months to 2025-09-30−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure10.4Net income, Q4 FY2025, three months to 2025-12-31$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure(9.5)Net income, Q1 FY2026, three months to 2026-03-31−$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure(6.4)Net income, Q2 FY2026, three months to 2026-06-30−$6.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure
Diluted EPS$ per share(0.61)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figurenot reported(0.62)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure(0.24)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure(0.22)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figurenot reported(2.49)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure(2.30)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$2.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure(0.11)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figurenot reported(0.58)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure(0.33)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure
Basic EPS$ per share(0.61)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figurenot reported(0.62)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure(0.24)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure(0.22)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figurenot reported(2.49)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure(2.30)Basic EPS, Q2 FY2025, three months to 2025-06-30−$2.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure(0.11)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figurenot reported(0.58)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure(0.33)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure

Balance sheet

Cash and equivalents$136.0m, Q2 FY2026
Shareholders' equity$72.3m, Q2 FY2026
Xilio Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m59.8Cash and equivalents, Q3 FY2023, at 2023-09-30$59.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figure44.7Cash and equivalents, FY2023, at 2023-12-31$44.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-11, accession 0001558370-25-002640.Report this figure34.0Cash and equivalents, Q1 FY2024, at 2024-03-31$34.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure74.9Cash and equivalents, Q2 FY2024, at 2024-06-30$74.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure61.3Cash and equivalents, Q3 FY2024, at 2024-09-30$61.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure55.3Cash and equivalents, FY2024, at 2024-12-31$55.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-23, accession 0001193125-26-118550.Report this figure89.1Cash and equivalents, Q1 FY2025, at 2025-03-31$89.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure122Cash and equivalents, Q2 FY2025, at 2025-06-30$121.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure104Cash and equivalents, Q3 FY2025, at 2025-09-30$103.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure138Cash and equivalents, FY2025, at 2025-12-31$137.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure150Cash and equivalents, Q1 FY2026, at 2026-03-31$150.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure136Cash and equivalents, Q2 FY2026, at 2026-06-30$136.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure
Current assets$m64.5Current assets, Q3 FY2023, at 2023-09-30$64.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001558370-23-018587.Report this figure48.1Current assets, FY2023, at 2023-12-31$48.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-11, accession 0001558370-25-002640.Report this figure69.2Current assets, Q1 FY2024, at 2024-03-31$69.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008068.Report this figure78.0Current assets, Q2 FY2024, at 2024-06-30$78.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011471.Report this figure63.3Current assets, Q3 FY2024, at 2024-09-30$63.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figure60.2Current assets, FY2024, at 2024-12-31$60.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-23, accession 0001193125-26-118550.Report this figure93.2Current assets, Q1 FY2025, at 2025-03-31$93.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure124Current assets, Q2 FY2025, at 2025-06-30$123.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure124Current assets, Q3 FY2025, at 2025-09-30$124.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure145Current assets, FY2025, at 2025-12-31$145.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure154Current assets, Q1 FY2026, at 2026-03-31$154.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure145Current assets, Q2 FY2026, at 2026-06-30$145.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure
Total assets$m77.8Total assets, Q3 FY2023, at 2023-09-30$77.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001558370-23-018587.Report this figure60.9Total assets, FY2023, at 2023-12-31$60.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-11, accession 0001558370-25-002640.Report this figure82.6Total assets, Q1 FY2024, at 2024-03-31$82.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001558370-24-008068.Report this figure89.9Total assets, Q2 FY2024, at 2024-06-30$89.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001558370-24-011471.Report this figure74.7Total assets, Q3 FY2024, at 2024-09-30$74.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figure71.1Total assets, FY2024, at 2024-12-31$71.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-23, accession 0001193125-26-118550.Report this figure104Total assets, Q1 FY2025, at 2025-03-31$103.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure134Total assets, Q2 FY2025, at 2025-06-30$133.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure134Total assets, Q3 FY2025, at 2025-09-30$133.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure155Total assets, FY2025, at 2025-12-31$154.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure163Total assets, Q1 FY2026, at 2026-03-31$163.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure154Total assets, Q2 FY2026, at 2026-06-30$154.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure
Current liabilities$m16.9Current liabilities, Q3 FY2023, at 2023-09-30$16.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001558370-23-018587.Report this figure16.0Current liabilities, FY2023, at 2023-12-31$16.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-11, accession 0001558370-25-002640.Report this figure31.6Current liabilities, Q1 FY2024, at 2024-03-31$31.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008068.Report this figure38.6Current liabilities, Q2 FY2024, at 2024-06-30$38.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011471.Report this figure38.0Current liabilities, Q3 FY2024, at 2024-09-30$38.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figure27.3Current liabilities, FY2024, at 2024-12-31$27.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-23, accession 0001193125-26-118550.Report this figure47.6Current liabilities, Q1 FY2025, at 2025-03-31$47.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure53.3Current liabilities, Q2 FY2025, at 2025-06-30$53.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure56.4Current liabilities, Q3 FY2025, at 2025-09-30$56.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure56.3Current liabilities, FY2025, at 2025-12-31$56.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure43.0Current liabilities, Q1 FY2026, at 2026-03-31$43.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure34.2Current liabilities, Q2 FY2026, at 2026-06-30$34.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure
Total liabilities$m25.3Total liabilities, Q3 FY2023, at 2023-09-30$25.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001558370-23-018587.Report this figure24.1Total liabilities, FY2023, at 2023-12-31$24.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-11, accession 0001558370-25-002640.Report this figure56.8Total liabilities, Q1 FY2024, at 2024-03-31$56.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001558370-24-008068.Report this figure56.5Total liabilities, Q2 FY2024, at 2024-06-30$56.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001558370-24-011471.Report this figure53.7Total liabilities, Q3 FY2024, at 2024-09-30$53.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figure53.5Total liabilities, FY2024, at 2024-12-31$53.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-23, accession 0001193125-26-118550.Report this figure93.0Total liabilities, Q1 FY2025, at 2025-03-31$93.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure127Total liabilities, Q2 FY2025, at 2025-06-30$126.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure142Total liabilities, Q3 FY2025, at 2025-09-30$141.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure119Total liabilities, FY2025, at 2025-12-31$119.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure90.9Total liabilities, Q1 FY2026, at 2026-03-31$90.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure82.0Total liabilities, Q2 FY2026, at 2026-06-30$82.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure
Shareholders' equity$m52.5Shareholders' equity, Q3 FY2023, at 2023-09-30$52.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001558370-24-014775.Report this figure36.8Shareholders' equity, FY2023, at 2023-12-31$36.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-23, accession 0001193125-26-118550.Report this figure25.8Shareholders' equity, Q1 FY2024, at 2024-03-31$25.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001558370-25-011477.Report this figure33.4Shareholders' equity, Q2 FY2024, at 2024-06-30$33.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure21.0Shareholders' equity, Q3 FY2024, at 2024-09-30$21.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure17.6Shareholders' equity, FY2024, at 2024-12-31$17.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure10.7Shareholders' equity, Q1 FY2025, at 2025-03-31$10.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure7.1Shareholders' equity, Q2 FY2025, at 2025-06-30$7.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure(8.1)Shareholders' equity, Q3 FY2025, at 2025-09-30−$8.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278837.Report this figure35.3Shareholders' equity, FY2025, at 2025-12-31$35.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure72.5Shareholders' equity, Q1 FY2026, at 2026-03-31$72.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure72.3Shareholders' equity, Q2 FY2026, at 2026-06-30$72.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345759.Report this figure

Cash flow

Operating cash flow−$18.8m, Q2 FY2026
Capital expenditure$19.0k, Q2 FY2026
Xilio Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(13.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001558370-24-014775. Derived: 9-month figure less the 6-month figure.Report this figure(13.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-11, accession 0001558370-25-002640. Derived: 12-month figure less the 9-month figure.Report this figure(10.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001558370-25-006996.Report this figure20.0Operating cash flow, Q2 FY2024, three months to 2024-06-30$20.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001558370-25-011477. Derived: 6-month figure less the 3-month figure.Report this figure(13.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$13.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-278837. Derived: 9-month figure less the 6-month figure.Report this figure(14.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure29.0Operating cash flow, Q1 FY2025, three months to 2025-03-31$29.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure(14.5)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345759. Derived: 6-month figure less the 3-month figure.Report this figure(17.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$17.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-278837. Derived: 9-month figure less the 6-month figure.Report this figure(2.0)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure(22.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$22.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure(18.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345759. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001558370-24-014775. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-11, accession 0001558370-25-002640. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-278837. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure0.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$401.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-345759. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-278837. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$95.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-118550. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2026, three months to 2026-03-31$556.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-218200.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-345759. Derived: 6-month figure less the 3-month figure.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.